On the other hand, ARNT, a transcriptional co-activator of AhR, has been implicated in renal fibrosis and is sought as a therapeutic target in CKD; strong experimental support exists for a mechanistic model in which FK506 induces renoprotection (Tampe et al., 2018; Haase, 2019). The gene discussed is AHR; the disease is chronic kidney disease.